Keywords: tasigna, achieves, rapid, response, cml, ph, new

Tasigna achieves rapid response in CML Ph+

Article | 15 December 2008

Print This

New results from two separate trials demonstrate that Novartis' Tasigna (nilotinib) 200mg capsules helps achieve rapid responses when used as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in